UBS Group AG - CARDIOL THERAPEUTICS INC ownership

CARDIOL THERAPEUTICS INC's ticker is CRTPF and the CUSIP is 14161Y200. A total of 27 filers reported holding CARDIOL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CARDIOL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,292
+3.0%
2,560
+2.4%
0.00%
Q2 2023$2,225
-77.8%
2,500
-87.8%
0.00%
Q1 2023$10,006
+78.2%
20,546
+86.6%
0.00%
Q4 2022$5,616
+180.8%
11,011
+450.6%
0.00%
Q3 2022$2,000
-71.4%
2,000
-63.7%
0.00%
Q2 2022$7,000
-46.2%
5,511
-37.4%
0.00%
Q1 2022$13,000
+30.0%
8,806
+64.1%
0.00%
Q4 2021$10,0005,3670.00%
Other shareholders
CARDIOL THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 2,953,300$2,643,2040.76%
Tejara Capital Ltd 645,457$577,6840.33%
AdvisorShares Investments LLC 1,205,788$1,109,3250.30%
AXS Investments LLC 773,535$706,1910.18%
FNY Investment Advisers, LLC 33,305$300.02%
Laird Norton Wetherby Trust Company, LLC 100,000$89,5000.01%
MGO ONE SEVEN LLC 100,000$89,5000.01%
Marble Harbor Investment Counsel, LLC 36,900$33,0260.00%
MONECO Advisors, LLC 14,000$12,5300.00%
Piscataqua Savings Bank 3,000$2,6700.00%
View complete list of CARDIOL THERAPEUTICS INC shareholders